Collaborate with provincial institutions for mutual benefit and win-win outcomes, jointly promoting the high-quality development of Jilin Province's pharmaceutical and healthcare industry.

2020 On September 8, Gao Junzhi, Director of the Jilin Province Institute for Drug Control, and his delegation visited our company for an inspection and research visit, during which both sides engaged in a warm and friendly exchange.

Director Gao Junzhi stated: "In response to the high-quality development requirements set forth by the Party Central Committee and the State Council, our province has actively stepped up efforts, firmly embracing innovation as the driving force for growth and vigorously promoting high-quality development. To establish our province as a leading hub for the pharmaceutical industry and further boost the development of Jilin Province's pharmaceutical and health-care sector, the Jilin Provincial Drug Administration has issued a directive to the Provincial Drug Testing Institute, emphasizing the initiative 'Bringing Services Directly to Enterprises, Providing Tailored Support to Each Company.' Since 2016, the Provincial Drug Testing Institute has annually dispatched its leadership team members or key technical experts to collaborate with enterprises on targeted technical assistance, a move that has been warmly welcomed by businesses across the board. Moving forward, the institute will continue to shift its mindset, intensify its research efforts, and play an even greater role in supporting enterprises' high-quality development—particularly in areas such as fostering secondary product innovations and upgrading industry standards. Today, at the invitation of the Jilin Provincial Pharmaceutical Industry Association, we are engaging in a fruitful exchange with Jilin Boda Weiye Pharmaceutical Co., Ltd. regarding innovative industrial technology research and development projects."

Chairman Duan Chengjun and General Manager Xie Wenbo expressed their gratitude for the support and care provided by the Provincial Institute of Drug Control. They also commended Director Gao Junzhi, Deputy Directors Shen Yuhua and Li Xiufen, along with other department heads and leaders, for their suggestions on enhancing scientific research elements and intensifying R&D efforts—initiatives that will help drive the company’s secondary product development and elevate industry standards. We strongly agree with the view that quality development can be boosted through powerful collaborations with R&D institutions.

Jilin Province Boda Weiye Pharmaceutical Co., Ltd., a high-tech enterprise backed by two cutting-edge R&D platforms—biological and chemical—was delighted to engage in an in-depth exchange with the Jilin Provincial Institute for Drug Control regarding innovative industrial technology research and development projects. We hope the pharmaceutical testing institute will continue providing support in areas such as establishing standard methodologies, enhancing standards, and offering training on the latest edition of the Pharmacopoeia. Bodaweiyi boasts multiple proprietary products with independent intellectual property rights, and by collaborating with provincial institutes to create a joint platform, we aim to foster mutual growth between the institutes and enterprises—promoting open cooperation, inclusiveness, shared benefits, and win-win outcomes. Looking ahead, Bodaweiyi Pharmaceutical will remain committed to advancing healthcare… Centered on the high-quality development of the pharmaceutical and health industry, we will pursue steady progress while striving for advancement, pushing the industry toward greater sophistication and reaching new heights. Working in unison with the National Institute for Drug Control, we will grow together and contribute even more to the development of our province's pharmaceutical sector.